Yi-Chun Lee

NPI: 1841274131
Total Payments
$22,016
2024 Payments
$146.01
Companies
22
Transactions
159
Medicare Patients
177
Medicare Billing
$20,214

Payment Breakdown by Category

Consulting$15,925 (72.3%)
Food & Beverage$4,195 (19.1%)
Travel$1,268 (5.8%)
Research$336.73 (1.5%)
Education$291.89 (1.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $15,925 4 72.3%
Food and Beverage $4,195 106 19.1%
Travel and Lodging $1,268 5 5.8%
Unspecified $336.73 8 1.5%
Education $291.89 36 1.3%

Payments by Type

General
$21,679
151 transactions
Research
$336.73
8 transactions

Top Paying Companies

Company Total Records Latest Year
Seagen Inc. $11,293 8 $0 (2022)
TESARO, Inc. $6,548 23 $0 (2019)
AstraZeneca Pharmaceuticals LP $1,015 18 $0 (2020)
Memic Innovative Surgery Inc. $760.00 6 $0 (2022)
Cumberland Pharmaceuticals, Inc. $527.07 60 $0 (2019)
Seattle Genetics, Inc. $336.73 8 $0 (2019)
Merck Sharp & Dohme Corporation $332.16 4 $0 (2019)
Genentech USA, Inc. $215.68 2 $0 (2017)
Clovis Oncology, Inc. $145.21 7 $0 (2019)
Medtronic, Inc. $136.26 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $146.01 5 COLOPLAST CORP ($45.02)
2022 $3,144 10 Seagen Inc. ($2,221)
2021 $9,072 6 Seagen Inc. ($9,072)
2020 $46.96 2 Eisai Inc. ($23.89)
2019 $3,016 50 TESARO, Inc. ($1,884)
2018 $5,479 53 TESARO, Inc. ($4,396)
2017 $1,112 33 TESARO, Inc. ($267.43)

All Payment Transactions

159 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
04/23/2024 On Target Laboratories, Inc Cytalux (Drug) Food and Beverage Cash or cash equivalent $30.50 General
Category: Oncology
03/16/2024 GlaxoSmithKline, LLC. Food and Beverage In-kind items and services $39.99 General
02/23/2024 COLOPLAST CORP Restorelle (Device) Food and Beverage In-kind items and services $18.38 General
Category: Women's Health
02/22/2024 COLOPLAST CORP Restorelle (Device) Food and Beverage In-kind items and services $26.64 General
Category: Women's Health
01/16/2024 Myriad Genetic Laboratories, Inc. MYRISK (Device) Food and Beverage In-kind items and services $30.50 General
Category: ONCOLOGY
12/02/2022 Seagen Inc. TIVDAK (Biological) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: Oncology
11/11/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Travel and Lodging Cash or cash equivalent $287.00 General
Category: Gynecological
11/11/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Travel and Lodging Cash or cash equivalent $71.00 General
Category: Gynecological
11/11/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Food and Beverage Cash or cash equivalent $26.00 General
Category: Gynecological
11/11/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Food and Beverage Cash or cash equivalent $24.00 General
Category: Gynecological
11/10/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Travel and Lodging Cash or cash equivalent $280.00 General
Category: Gynecological
11/10/2022 Memic Innovative Surgery Inc. Anovo Surgical System (Device) Food and Beverage Cash or cash equivalent $72.00 General
Category: Gynecological
09/22/2022 Medtronic, Inc. LIGASURE (Device) Food and Beverage In-kind items and services $136.26 General
Category: Vessel Sealing
05/17/2022 CooperSurgical, Inc. Summit Doppler (Device) Food and Beverage In-kind items and services $27.05 General
Category: Devices
03/18/2022 Seagen Inc. Food and Beverage In-kind items and services $120.75 General
12/17/2021 Seagen Inc. TIVDAK (Biological) Consulting Fee Cash or cash equivalent $8,325.00 General
Category: Oncology
12/17/2021 Seagen Inc. TIVDAK (Biological) Travel and Lodging In-kind items and services $100.00 General
Category: Oncology
12/17/2021 Seagen Inc. TIVDAK (Biological) Food and Beverage In-kind items and services $9.35 General
Category: Oncology
12/03/2021 Seagen Inc. TIVDAK (Biological) Travel and Lodging In-kind items and services $529.69 General
Category: Oncology
12/03/2021 Seagen Inc. TIVDAK (Biological) Food and Beverage In-kind items and services $55.80 General
Category: Oncology
12/03/2021 Seagen Inc. TIVDAK (Biological) Food and Beverage In-kind items and services $51.91 General
Category: Oncology
02/13/2020 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $23.07 General
Category: Oncology
01/15/2020 Eisai Inc. Lenvima (Drug) Food and Beverage Cash or cash equivalent $23.89 General
Category: Oncology
12/20/2019 Clovis Oncology, Inc. Rubraca (Drug) Food and Beverage In-kind items and services $22.08 General
Category: Oncology
12/20/2019 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $20.60 General
Category: Oncology

Research Studies & Clinical Trials

Study Name Company Amount Records
Safety and Efficacy of Tisotumab Vedotin in Combination With Other Cancer Agents in Subjects With Cervical Cancer Seattle Genetics, Inc. $336.73 8

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 87 122 $41,931 $11,032
2022 3 41 87 $25,290 $6,683
2021 1 12 13 $1,213 $342.98
2020 2 37 63 $8,820 $2,155
Total Patients
177
Total Services
285
Medicare Billing
$20,214
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 25 37 $11,581 $2,952 25.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 17 17 $9,843 $2,588 26.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 14 21 $9,282 $2,539 27.4%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 17 33 $5,709 $1,524 26.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 14 14 $5,516 $1,429 25.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 36 $11,520 $3,036 26.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 15 15 $8,910 $2,308 25.9%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 14 36 $4,860 $1,339 27.5%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 12 13 $1,213 $342.98 28.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 23 46 $7,423 $1,750 23.6%
99212 Established patient office or other outpatient visit, typically 10 minutes Facility 2020 14 17 $1,397 $404.87 29.0%

About Yi-Chun Lee

Yi-Chun Lee is a Obstetrics & Gynecology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841274131.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yi-Chun Lee has received a total of $22,016 in payments from pharmaceutical and medical device companies, with $146.01 received in 2024. These payments were reported across 159 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($15,925).

As a Medicare-enrolled provider, Lee has provided services to 177 Medicare beneficiaries, totaling 285 services with total Medicare billing of $20,214. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Obstetrics & Gynecology
  • Location Brooklyn, NY
  • Active Since 12/01/2005
  • Last Updated 07/08/2007
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • NPI Number 1841274131

Products in Payments

  • TIVDAK (Biological) $11,172
  • ZEJULA (Drug) $6,548
  • LYNPARZA (Drug) $903.58
  • Anovo Surgical System (Device) $760.00
  • KEYTRUDA (Biological) $312.70
  • Ethyol (Drug) $259.54
  • Avastin (Biological) $215.68
  • Caldolor (Drug) $180.99
  • Rubraca (Drug) $145.21
  • LIGASURE (Device) $136.26
  • Surgical Care - Floseal (Biological) $117.90
  • RS Harmony Test Related Products (Device) $117.75
  • FASLODEX (Drug) $111.89
  • Vaprisol (Drug) $52.12
  • Lenvima (Drug) $46.72
  • DERMABOND Portfolio (Device) $46.56
  • Restorelle (Device) $45.02
  • AQUACEL AG (Device) $38.71
  • DAV-Arista AH (Device) $31.58
  • Cytalux (Drug) $30.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Brooklyn